world. Prenatal iron-folate supplementation, despite international recommendations [2] , has had poor success in many Third World countries, primarily due to inadequate supplies and poorly managed logistics of distribution [3] . Because maternal micronutrient deficiencies coexist and are widespread in developing countries, there has been a recent global movement to advance the use of a daily prenatal multivitamin-mineral supplement that goes beyond iron-folate alone. However, empirical evidence for a beneficial effect of such a supplement on either maternal or infant outcomes is yet to be known. Numerous randomized clinical trials of multiple micronutrient supplementation in the developed world have failed to show any beneficial impact on birth weight or perinatal mortality [4] , although the populations in which these trials were conducted had a low probability of being deficient. In a randomized clinical trial among HIV-1-infected pregnant women in Tanzania, multivitamins (given in multiples of the recommended dietary allowance, RDA) resulted in significant reductions in low birth weight, severe preterm (Ͻ34 weeks) birth, and fetal deaths [5] . The implications of these findings for non-HIV populations are not clear. It is critical that the health and nutritional effects of a prenatal micronutrient supplement are well established before initiating interventions on a global scale in the developing world. This chapter summarizes the existing knowledge on the efficacy of single micronutrients in improving infant outcomes and presents the results of one of the first trials from Nepal that tested the effects of a multiple micronutrient supplement on infant outcomes. Data on maternal micronutrient supplementation on infant health outcomes are scant. This chapter focuses on the study from Nepal to provide initial insights into the potential effects, both beneficial and harmful, of maternal micronutrient supplementation on fetal and infant outcomes. Because half of the world's low birth weight babies are born in south Asia, the results from this study have broadbased implications.
Impact of Maternal Supplementation with Single Micronutrients on Infant Outcomes
Vitamin A Few studies have examined the impact of antenatal vitamin A supplementation on infant and maternal health due largely to the concerns regarding its teratogenic effects at large doses (Ͼ10,000 IU) [6] . Yet in many regions of the developing world, maternal vitamin A deficiency is common and women develop night blindness during pregnancy which is associated with an increased risk of both maternal [7] and infant mortality [8] . Recent surveys show that maternal night blindness may range from 5 to 18% in many countries of south and southeast Asia [9, 10] . A recent trial in Nepal showed that weekly vitamin A or ␤-carotene supplementation among women of reproductive age reduced maternal mortality by 40% [11] . Yet, the same study Maternal Micronutrient Supplementation showed that neither supplement had any impact on infant mortality [12] (table 1) or early neonatal weight (unpublished, West et al.) . Two studies among HIV-1-infected pregnant women have found no impact of vitamin A supplementation on the incidence of low birth weight [5, 13] . One of these studies [13] showed a significant reduction in preterm delivery (Ͻ37 week of gestation). One study in Malawi showed that vitamin A supplementation reduced the occurrence of low birth weight from 21 to 14% (p Ͻ 0.03) among HIV-1 women [14] . Thus, the evidence regarding a beneficial impact of vitamin A supplementation among pregnant women on newborn weight or infant health is conflicting and derived largely from studies among HIV-1-infected women. More work is needed in this area among non-HIV populations. The impact on maternal mortality is currently being tested in other regions of the world.
Vitamin D
A recent Cochrane review found 2 trials involving a small number of women (n ϭ 232) on vitamin D supplementation during pregnancy [15] . One trial showed a lower number of low birth weight infants among supplemented mothers, while the other showed that the supplemented group had lower birth weight. The authors conclude that 'there is not enough evidence to evaluate the effects of vitamin D supplementation during pregnancy'.
Folic Acid
Based on the Cochrane review, there is little evidence to support any effect of folic acid supplementation on maternal and infant outcomes, except for a nonsignificant reduction in the incidence of low birth weight (relative risk, RR, ϭ 0.73, 95% confidence limit, CL, 0.47, 1.13) [16] . Studies examining the impact of periconceptional folate and/or multivitamin supplementation on neural tube defects have found a small reduction in stillbirth rate of 22%, although the confidence interval around this reduction includes 1 [17] .
Vitamin B 6
Only 1 trial of 371 women was found that examined the impact of pyridoxine supplementation compared to a control group of pregnant women [18] . This trial did not examine any pregnancy-related outcomes but found that supplementation was associated with a significant reduction in dental decay.
Iron
A comprehensive review on the impact of iron and/or folate supplementation concluded that 'the currently available evidence from studies with designs appropriate to establish a causal relationship is insufficient to support or reject this practice (of supplemental iron during pregnancy) for the purposes of raising birth weight or lowering the rate of preterm birth' [19] . [20] which analyzed 20 trials found 'no detectable effect on any substantive measure of either maternal or fetal outcome'. Only 1 trial of selective versus routine iron supplementation showed a lower perinatal mortality rate due to iron supplementation, although the number of deaths was only 13. A randomized, double-masked trial of iron supplementation (100 mg elemental iron) during the third trimester of pregnancy in Niger showed no effect on the birth weight of infants although the average birth length of infants of iron-supplemented mothers was higher compared to those receiving a placebo [21] . In the same study maternal iron supplementation resulted in a significant reduction in fetal/neonatal death (7.1 vs. 1%; p ϭ 0.03) [22] , although, again, the number of deaths was small.
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Zinc
The Cochrane review that includes 5 trials from the UK and the US found a significant reduction in preterm delivery, and a small potential reduction in low birth weight due to maternal zinc supplementation [23] , but this has not been confirmed in other trials in developing countries. A randomized, placebo-controlled trial from Bangladesh found that antenatal zinc supplementation (30 mg daily) had no effect on birth weight, length or incidence of prematurity [24] . Similarly, in Peru, birth weight among women receiving 15 mg daily zinc with iron-folate supplementation during pregnancy was no different from those receiving iron-folate alone [25] . In the study in Bangladesh, low birth weight infants experienced a reduction in the incidence of acute diarrhea, dysentery and impetigo due to maternal zinc supplementation [26] , suggesting a potential positive impact on their immune system despite the lack of impact on birth weight per se. In the same cohort, however, maternal zinc supplementation was associated with lower scores on mental and psychomotor development indices in infants [27] , suggesting that prenatal zinc supplementation may have both a beneficial and harmful effect on infants, depending on the outcome that was measured.
Magnesium
Although the Cochrane review [28] suggests significant reductions in preterm delivery, low birth weight and small-for-gestational age incidence due to supplementation with magnesium during pregnancy, these results were influenced strongly by 1 trial, the exclusion of which rendered all relative risk estimates nonsignificant. The quality of most of the trials included in the analysis was questionable, as a result of which the authors conclude that 'there is not enough high quality evidence to show that dietary magnesium supplementation during pregnancy is beneficial'. Recently a large multicenter trial of 10,141 pre-eclamptic women in 33 countries showed that magnesium Maternal Micronutrient Supplementation sulfate halved the risk of eclampsia and reduced the risk of maternal death (RR ϭ 0.55, 95% CL 0.26, 1.14), although the risk of infant death was not altered (RR ϭ 1.02) [29] .
Calcium
The effect of maternal calcium supplementation on birth outcomes has been examined in the context of preventing hypertensive disorders and related problems of pregnancy. Calcium supplementation does not appear to have an effect on preterm delivery or stillbirth or infant death rate [30] . There was a small reduction (RR ϭ 0.83, 95% CL 0.71-0.98) on the incidence of low birth weight, although this needs confirmation by studies in developing countries. Many of these studies used 1-2 g of daily calcium, but were conducted among populations with adequate dietary intakes of calcium. Future studies should include communities with a low dietary intake of calcium using lower dosages of calcium for supplementation during pregnancy.
This brief overview of the efficacy of single, daily prenatal micronutrient supplements reveals mostly weak effects on infant outcomes largely due to inappropriately designed studies and lack of studies in populations with nutritional deficiencies. The study in Nepal, described below in some detail, is one of the first trials to examine the effects of alternative combinations of prenatal micronutrients on birth weight and infant survival in a rural, malnourished population in South Asia.
The Nepal Study
Study Design and Methods
The Nepal study [31, 32] was a double-masked, cluster-randomized, community-based trial to assess the impact of alternative combinations of micronutrients given during pregnancy and up to 3 months postpartum on birth weight, preterm delivery and infant mortality in rural Nepal. Previously, in this population we had shown no impact of maternal vitamin A or ␤-carotene supplementation on birth weight (unpublished, West et al.) or infant mortality [12] . Yet, both these nutrients reduced pregnancy-related mortality by 44% (RR ϭ 0.56, 95% CL 0.37, 0.84) [11] . We randomized 426 communities to the following 5 supplement regimens: C ϭ vitamin A (1,000 g retinol equivalents, control); FA ϭ vitamin A ϩ folic acid (400 g); FAFe ϭ vitamin A ϩ folic acid ϩ iron (60 mg); FAFeZn ϭ vitamin A ϩ folic acid ϩ iron ϩ zinc (30 mg), and MN ϭ vitamin A ϩ folic acid ϩ iron ϩ zinc ϩ other micronutrients 1 .
Vitamin A alone was the control group. Each nutrient approximated a US RDA for a pregnant or lactating woman [33] , except for iron and zinc which were given at a level twice the RDA for pregnancy. The amount of iron (60 mg) is the WHO recommended dosage for an antenatal supplement in countries where anemia prevalence is Ͼ40% [2] . Because a competitive inhibition of zinc uptake by iron has been reported to occur at ratios of Ͼ2:1 [34] , the amount of zinc in the supplement was set at 30 mg (twice the RDA) to achieve an iron:zinc ratio of 2:1.
Women of reproductive age were first screened for their eligibility to become pregnant over the course of a year by 426 local female workers hired on the project. Women currently pregnant, breast-feeding an infant Ͻ9 months of age, sterilized, widowed or menopausal were excluded. The remaining women were visited once every 5 weeks for a year and asked if they had menstruated in the past 30 days. Amenstrual women were administered a human chorionic gonadotropin-based urine test for detection of pregnancy. Using this method, almost 50% were enrolled within 9 weeks and 90% with 16 weeks of gestation. Upon enrolment, women were provided with a bottle containing 15 supplements according to their allocation code, with instructions to take one each night before going to bed. The local female workers visited the participants twice each week to monitor compliance, ascertain pregnancy status and outcome, and to replenish the supplements. Daily supplementation was continued through 12 weeks postpartum in the event of a live birth, and for at least 5 weeks following a miscarriage or stillbirth.
Almost 97% of births in the study area occurr at home, assisted by traditional birth attendants, relatives and neighbors [11] . Every effort was made to obtain birth weight and other anthropometric measurements as soon after birth as possible. Once birth was reported, the anthropometrist went to the home to perform 'day-of-birth' assessment, which included weight, length, and head and chest circumference measurements. Low birth weight was defined as weight Ͻ2.5 kg taken within 72 h of birth. Small-for-gestational age was defined as weight below the 10th percentile of the gestational age, sexspecific US reference for fetal growth [35] . Gestational age was calculated using the reported 1st day of the last menstrual period at the initial pregnancy interview. Preterm delivery was defined as a birth occurring before 37 weeks of gestation.
Over a year, 4,096 pregnancies ended in at least 1 live birth, with a total of 4,130 children being born alive. Approximately 80% of these were measured within 72 h and 70% within 24 h of birth. Median compliance was high at 88% and comparable across treatment groups.
Impact on Low Birth Weight, Preterm Delivery and Small-for-Gestational Age
The incidence of low birth weight in the control group was high at 43%. The combinations of folic acid ϩ iron and multiple micronutrients reduced the incidence of low birth weight by a modest 16% (RR ϭ 0.84, 95% CL 0.72, 0.99) and 14% (RR ϭ 0.86, 95% CL 0.74, 0.99), respectively (table 2). The combinations of folic acid alone or folic acid ϩ iron ϩ zinc did not have any impact on birth weight. The mean effect size in the folic acid ϩ iron group was 37 g (95% CL Ϫ16, 90) and that in the multiple micronutrient group was 64 g (95% CL 12, 115). Both folic acid ϩ iron and multiple micronutrients increased newborn head and chest circumference, but not length.
The incidence of small-for-gestational age was somewhat reduced with folic acid ϩ iron supplementation, compared to controls (RR ϭ 0.91, 95% CL 0.83, 1.00). There was no effect on preterm birth; all RR compared to controls were approximately 1.0. Folic acid ϩ iron and multiple micronutrient effects may have differed in the distribution of the added weight, with multiple micronutrients increasing weight disproportionately at the upper end. The proportion of infants with weights of Ն3.3 kg was 50% higher (RR ϭ 1.5, 95% CL 0.96, 2.2) in the multiple micronutrient group but similar to controls (RR ϭ 1.1, 95% CL 0.72, 1.8) in the folic acid ϩ iron group. Although modest, the magnitude of the effect of micronutrient supplementation is well within the range reported for maternal food supplementation: a 25-to 84-gram increase in birth weight for every additional 10,000 kcal consumed during pregnancy [36] . In the present setting where the mean maternal weight at baseline was low (ϳ43.5 kg), largely due to energy and protein malnutrition, micronutrient supplementation alone, in the absence of food supplementation, was able to ameliorate this huge burden of low birth weight by 14-16%.
Adding zinc appeared to prevent the beneficial effect on birth weight and other growth parameters observed with iron and folic acid alone. Birth weight was higher by 53 g (95% CL 00, 108) among newborns of mothers who received folic acid ϩ iron over those who received the same supplement with added zinc. Competition between bivalent iron and zinc for mucosal uptake in the gut may result in one interfering with the absorption of the other [38] . Previously we have shown that improvement in the hemoglobin (Hb) concentration due to iron-folate treatment, although not significant, was lower (4.8 g/l) among pregnant Nepalese women receiving supplemental zinc compared to those not receiving zinc (7.8 g/l) [39] . In the present study, the Hb concentration improved by 13.8 g/l in the folic acid ϩ iron group compared to only 10.0 g/l in the folic acid ϩ iron ϩ zinc group (data not shown). Although this difference was not statistically significant, it is suggestive of an inhibitory effect of zinc on iron. This potential inhibitory action of zinc may have contributed to the lack of birth weight gain as seen among those who were supplemented with iron-folic acid alone.
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The full complement of micronutrients (including folic acid, iron and zinc), however, did increase birth weight and other measures of growth, suggesting mechanisms other than those mediated by iron or Hb. The efficacy of a multiple micronutrient supplement that excluded zinc was not tested in this trial. If we assume that zinc in the multiple micronutrient continued to reverse the effect of iron on birth weight, it can be postulated that the other nutrients in the supplement (mostly B-complex vitamins) on their own may have had a larger effect than iron alone. For example, we know that B-complex vitamins participate in numerous aspects of intermediary protein, lipid and carbohydrate metabolism that regulate energy and nitrogen utilization, which could affect fetal growth [39] . The study among HIV-1-infected women in Tanzania found that multivitamin supplementation (that did not include any zinc) decreased the risk of low birth weight by 44% [5] . Our results suggest that, for this rural Nepalese population, an optimal multiple micronutrient supplement for reducing low birth weight and anemia should probably include less zinc.
Impact on Fetal Loss, Perinatal, Neonatal, and 3-Month Infant Mortality
There is little evidence on the impact of maternal micronutrient supplementation on infant health and survival. Studies of maternal zinc supplementation in Bangladesh and Peru have shown an improvement in the health [24] and fetal neurodevelopment [41] without any impact on birth weight. In Nepal, we examined the impact of the four combinations of micronutrient supplements on miscarriage, and 3-month infant mortality [32] . Rates of miscarriage did not differ by treatment group and ranged between 12 and 15% (data not shown). Kaplan-Meier analysis in the 1st 6 months of life showed higher survival among infants of mothers receiving folic acid with or without added iron or iron ϩ zinc compared to controls ( fig. 1) . However, the individual treatment-control differences were not statistically significant. The mortality reduction was most apparent through the first 3 months of life, after which the curves tended to parallel each other. Relative risks of 3-month mortality ranged from 0.78 to 0.89 in the 3 groups compared to controls, with confidence intervals including 1. The mortality rate among infants in the multiple micronutrient group was similar, and consistently, even slightly worse than that of infants in the control group, such that the highest infant mortality in each period of life was observed in the multiple micronutrient group. This was surprising as multiple micronutrients were noted to have the highest mean increase in birth weight. When treatment effects were stratified by preterm and term delivery, a significant interaction was revealed (table 3) . Among preterm births, supplementation with folic acid and folic acid ϩ iron was associated with a 45-50% reduction in 3-month infant mortality. Adding zinc or other micronutrients to folic acid ϩ iron did not show any additional benefit and perhaps even attenuated the protective effect, as reflected by a lower relative risk and confidence intervals that included 1. In contrast, there appeared to be little survival benefit due to supplementation among term infants. In fact, term infants of mothers who were supplemented experienced a slightly higher mortality relative to the controls, with the highest risk of mortality being observed among those who received the multiple micronutrient supplement (RR ϭ 1.74, 95% CL 1.00-3.04). supplementation, which had a significant impact on birth weight, failed to show any survival benefit. These seemingly contradictory results suggest that improvement in infant survival observed with maternal nutritional supplementation might not always be mediated through increases in birth weight, as suggested previously [42] . It is argued that preterm birth and not birth size per se increases mortality risk. Birth weight is good in as much as it captures small preterm babies, but direct measurement of prematurity is much better to have [43] . In the present study, while the risk of preterm itself remained unchanged, the elevated risk of poor survival among these infants was ameliorated through maternal supplementation. Excess perinatal and neonatal mortality may operate through several mechanisms mediated by preterm birth and severe intrauterine growth retardation or independent of these mediators ( fig. 3) . For instance preterm infants may be at an increased risk of oxidative stress and free radical damage, especially in the presence of a deficient maternal antioxidant state [44] . A lowered immune status due to preterm birth or fetal growth retardation can result in increased risk of early infant morbidity and mortality. Congenital abnormalities caused by maternal nutritional deficiencies also contribute to perinatal mortality. Finally, perinatal and neonatal deaths may occur due to complications of pregnancy and delivery such as fetal malpresentation, eclampsia, intrapartum bleeding, multiple births, prolonged labor, placenta previa and premature rupture of the membranes [45] . Birth weight may or may not influence these mechanisms. 
Birth Weight and Infant Mortality: A Role of Preterm Birth
Hypotheses Regarding Adverse Effect of Multiple Micronutrient Supplement on Infant Mortality
It is not clear why multiple micronutrient supplementation failed to show the same overall reduction in mortality observed with folic acid or with folic acid ϩ iron. We examined the relationship between birth weight and infant mortality by treatment group (fig. 4 ). There appeared to be a linear relationship between birth weight and infant mortality in each of the treatment groups, except the multiple micronutrient group. In this group, there was a suggested trend of increasing mortality at the upper end of the birth weight categories. The excess mortality risk due to multiple micronutrient supplementation, as shown before, was apparent only in the term infants ( fig. 2) . When treatment effects on high birth weight (Ն3.3 kg) were examined by term birth, we found that while none of the supplements increased high birth weight in preterm births, multiple micronutrients significantly increased the risk of high birth weight relative to controls in term births (RR ϭ 1.71, 95% CL 1.10-2.65). High birth weight was associated with symptoms of birth asphyxia. The risk of birth asphyxia was also higher among term infants whose mothers received multiple micronutrients relative to controls. Thus it is likely that among term infants, multiple micronutrient supplementation resulted in high birth weight, which consequently may have increased the risk of birth asphyxia and infant mortality. Multiple micronutrients may have lead to a protective survival effect among preterm infants as shown in figure 2 , but it also increased the risk of mortality among term infants. These countervailing influences may have cancelled each other out which resulted in multiple micronutrients seemingly having no overall benefit on mortality.
The South Asian Context
The findings of this study may be most relevant to rural South and, possibly, Southeast Asia where maternal malnutrition, including wasting and stunting are highly prevalent. Indeed, it was surprising to find increased problems of asphyxia among newborns who were above 3.2 kg weight at birth, a birth weight which would be considered normal in most other regions of the world. While prepregnancy nutritional status and weight gain during pregnancy influences birth weight, gestational age at birth is a stronger determinant of birth size as well as subsequent infant health and survival. Our analysis suggested that the micronutrients most benefited infant survival of short mothers (height Ͻ150 cm) who were preterm and may have had the most detrimental effect on infants of term mothers who had a height of Ն150 cm. It is likely that the components of fetal weight gain due to micronutrient supplementation among the better nourished women who carried their fetus to term may be quite different from those who were poorly nourished and had a shorter gestational duration. The mechanisms of these differences in intrauterine growth are not clear, yet our data suggest that while correcting iron deficiency may have affected low birth weight in the group receiving folic acid ϩ iron, other micronutrients such as the B-complex vitamins may have caused the birth weight differences in the multiple micronutrient supplement.
Conclusions and Future Research
One other study which was conducted in a Mexico semirural population found that daily maternal multiple micronutrient supplementation had no additional impact on birth weight and other aspects of birth size compared to iron alone [46] . These findings corroborate the results of the study in Nepal which showed that multiple micronutrients conferred no additional benefit over iron folate in reducing low birth weight. The preliminary evidence generated from these trials, combined with a potential harm caused by multiple micronutrients is adequate to give a pause to the use and promotion of such a supplement in the developing world. Nutrient-nutrient interactions may be more complex than previously thought, especially in the context of multiple micronutrient deficiencies, some of which may be more limiting for birth weight and infant survival than others. The Nepal study suggests that, for this rural Nepalese population, an optimal multiple micronutrient supplement for reducing low birth weight and anemia should probably include less zinc. Birth weight is strongly associated with infant mortality. Yet, the Nepal study indicates that improvements in survival may or may not be mediated by birth weight. Thus future trials testing maternal micronutrient supplementation should include, beyond birth weight, infant health and mortality as outcomes. The Nepal study questions conventional knowledge and views on maternal micronutrient supplementation and its use for improving infant survival and health in the developing world. While it goes far in supporting the use of folic acid alone or with iron, it gives a basis for 'pause' before the world rushes forward toward multiple micronutrient supplementation without understanding its potential public health impact. Many research questions need to be urgently addressed in this regard. What is the optimum combination of prenatal micronutrients that will result in a health benefit? For which outcomes and which population? What is the etiologic fraction of maternal micronutrient deficiency in early infant mortality? More research is clearly needed in these areas to better inform policy and programs in the developing world.
numbers, even if it is statistically significant, it is not really very relevant to have a p value of only Ͻ0.05. The other comment I have is that your population is presumed to be malnourished, the average weight of the pregnant women was 42 kg. Therefore this study will not be applicable to a normal healthy population, and also the conclusion. Is that correct?
Dr. Christian: That is why I stated with my concluding slide that these results are probably most applicable to populations in south Asia and south-east Asia. Regarding your first comment, I agree with you completely with the sample size issue. And despite having 5,000 women we did not have adequate power to look at the mortality differences, which is a problem. But you are right that with this sample size, we were able to pick up small birth weight differences by treatment group. Touching on the same point of sample size, it seems that, as you said, there was limited power, we didn't see the number of cases. How many deaths were due to asphyxia? Do you think that these findings could be a potential explanation for those adverse effects? The second question, could the supplement dose that you used play a role in the overall lack of effect of the multiple micronutrients with respect to birth weight or any other outcomes?
Dr. Christian: With regard to your first comment/question, I think that yes, this could be purely a chance finding and therefore it needs to be examined again in other populations. Dr. Bates started the first presentation by putting up a quote that said you could be either completely wrong if you came up with some different kind of finding, or you have made a new discovery. I think that with the results of this study we are standing in the middle ground somewhere and we do not really know if this is a fluke finding or whether we have made a new discovery. The point you made about the absolute difference: I showed you relative risks and what we infer with regard to the magnitude of the increased risk and how we weigh that against the magnitude of the protective effect in survival. I think those are very good points. The problem of high birth weight was quite low and so the absolute change in increased mortality was quite low. I am not quite sure about the dosage. We have collected serum samples from 1,000 women across 200 in each group at a baseline and follow-up, and we are going to look carefully at the serum indicators to see if they have an impact on status or not. With regard to iron we were able to show a significant impact on hemoglobin concentrations, and serum ferritin, serum iron and transferrin receptor.
Dr. Saadah: Did you eliminate confounding factors like maternal diabetes which might adversely influence birth weight?
Dr. Christian: No, we did not, they were all included in the study, and because antenatal care in this population is very low, almost nonexistent, they weren't screened on a regular basis for diabetes.
Dr. Verhoef: I continue to be puzzled by the apparent lack of effect of zinc supplementation in pregnancy on growth in children, especially regarding the dramatic effects that have been achieved in infancy in for example the trials that our group has carried out in Ethiopia, and I would like to exchange my views about that. From your trial it seems that at baseline the groups are fairly comparable regarding maternal weight, which seems to indicate that it is unlikely to be a major confounder and yet in the analysis you adjusted for that. That seems to indicate that you have considered that nevertheless to be a potential confounder, whereas I would think that if zinc is supplemented, it is very likely that maternal weight would increase and that could indicate a mediating factor in the relationship between zinc supplementation and birth weight of children. If you adjust for that, as you seem to have done in your analysis, it seems that the effect that you were looking for might have inadvertently been eliminated. Could you comment on that and why didn't you adjust for maternal height instead of weight because zinc supplementation obviously wouldn't have an effect on maternal height.
Dr. Christian: We adjusted for baseline weight and that was before supplementation. Secondly the reason we adjusted for maternal weight was, even though the groups were highly comparable, because of our large sample size the small differences between the treatment groups were statistically significantly different, and so I have done both adjusted and unadjusted analysis of the results.
Dr. Verhoef: So how do you interpret the lack of effect there? Is that possibly because zinc supplementation would inhibit absorption of iron, is that the issue?
Dr. Christian: Yes, that is what we think and that is also suggested when you look at the hemoglobin indicators because the increase in hemoglobin was not as high with added zinc.
Dr. Verhoef: On the basis of these data would you advise against zinc supplementation in pregnancy or do you think that would be a premature conclusion?
Dr. Christian: Our colleagues have looked at all the trials of maternal zinc supplementation that have been conducted in developing countries to look at its impact on birth weight, and their finding is that zinc supplementation has no impact on birth weight [1] . There is one study from Bangladesh by Osendarp [2] which found that while zinc supplementation in women during pregnancy had no impact on the birth weight of the infants, the low birth weight infants in that study, when followed up through 6 months of life, had a lower incidence of acute lower respiratory infections and diarrheal diseases. But again in the same study, published recently in the Lancet, by McGregor and Osendarp [3] found that maternal zinc supplementation was associated with a significantly lower Bayley score. But with regard to antenatal zinc supplementation. I am not quite sure if there is any bottom line because based on this study some outcomes are positively affected and some are not affected at all and then others are negatively affected.
Dr. Rao: In our country we have a program of child survival and safe motherhood in which an iron folic acid supplement is given to all antenatal mothers expecting a good fetal outcome. However, in a control area apart from iron folic acid supplementation, zinc and also extra protein supplementations were given to the mothers in the last two trimesters of pregnancy, and it was found that the ultimate birth weight of the babies increased by 250 g and more. Also there were no perinatal complications like asphyxia. So apart from the micronutrient supplementation, there is also a need to supplement protein to these antenatal mothers.
Dr. Al Saeid: I just wanted to mention a similar point. Did you make sure that those mothers, especially since they were apparently malnourished, received enough calories, enough protein and enough carbohydrates? Maybe the effect of micronutrients will not be apparent if someone is already malnourished.
Dr. Christian: I agree with you completely. I think that what is limiting in the diet is energy, calories, and whatever the micronutrient did was small. They need more food during pregnancy.
Dr. Delange: What was the rationale for including copper in the micronutrient group? Secondly, I was impressed by the extremely high birth weight of some of the babies born in Norway, which suggests that perinatal prenatal monitoring in this highly sophisticated country was perhaps a bit questionable. How many of these mothers were diabetic, do you know that?
